Prinaberel

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePrinaberel
Drug Alias Nameprinaberel普林贝瑞prinaberelum普利贝瑞ERB-041 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor beta agonists
TargetsEstrogen receptor beta
Therapy Area/IndicationsPelvic PainDysmenorrheaLong QT Syndrome +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth LlcWyeth Pharmaceuticals IncWyeth Research +[4] 
Active IndicationsN/A
Inactive IndicationsPelvic PainDysmenorrheaLong QT Syndrome +[7] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG